Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial. (nature.com)

Authors: Nadeem O … Ghobrial IM Journal: Nature Medicine Published: 2026-04-20 DOI: https://doi.org/10.1038/s41591-026-04365-y